Chan K
J Clin Hosp Pharm. 1981 Jun;6(2):107-16. doi: 10.1111/j.1365-2710.1981.tb00982.x.
A detailed study on the plasma and urine levels of pethidine and its major basic metabolite, norpethidine, was carried out after intravenous and oral administration of pethidine, under conditions of controlled acidic urinary pH, to two healthy subjects who had previously shown significant difference in the urinary recovery of pethidine after the intramuscular administration of a standard dose. Utilizing the data of area under plasma concentration-time curve and cumulative urinary excretion of pethidine, similar values of renal clearance of the drug were obtained after separate intravenous and oral administration to the same subject. There is an overall difference in the renal clearance and metabolic pattern of the drug between these two subjects under conditions of controlled acidic urinary pH. It is postulated that variation in the overall elimination of pethidine and other weakly basic drugs can only be elucidated under conditions and may be interpreted in terms of differences in the renal clearance and hepatic biotransformation of the drug.
在控制尿液酸性pH值的条件下,对两名健康受试者静脉注射和口服哌替啶后,对其血浆和尿液中哌替啶及其主要碱性代谢物去甲哌替啶的水平进行了详细研究。这两名受试者在肌肉注射标准剂量哌替啶后,尿液回收率曾显示出显著差异。利用血浆浓度-时间曲线下面积和哌替啶累积尿排泄的数据,在对同一受试者分别进行静脉注射和口服给药后,获得了相似的药物肾清除率值。在控制尿液酸性pH值的条件下,这两名受试者之间药物的肾清除率和代谢模式存在总体差异。据推测,只有在特定条件下才能阐明哌替啶和其他弱碱性药物总体消除的差异,并且可以根据药物肾清除率和肝生物转化的差异来解释。